title: Lobaplatin in advanced urothelial tract tumors. The Genitourinary Group of the European Organization for Research and Treatment of Cancer (EORTC).
authors.affiliation: San Raffaele Scientific Institute, Rome, Italy.
authors.forename: C N
authors.initials: CN
authors.lastname: Sternberg
authors.forename: P
authors.initials: P
authors.lastname: de Mulder
authors.forename: S
authors.initials: S
authors.lastname: Fossa
authors.forename: S
authors.initials: S
authors.lastname: Kaye
authors.forename: T
authors.initials: T
authors.lastname: Roberts
authors.forename: A
authors.initials: A
authors.lastname: Pawinsky
authors.forename: S
authors.initials: S
authors.lastname: Daamen
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003503:Cyclobutanes / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000139:chemically induced; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D003503:Cyclobutanes; D009944:Organoplatinum Compounds; C066228:lobaplatin